The Morning Briefing: Vaccination trials, research
"The Morning Briefing" is SmartPlanet's daily roundup of must-reads from the web. This morning we're reading about vaccination trials and research.
1.) First alcoholism vaccine to begin preclinical trials. Testing on a vaccine for alcoholism is about to begin in Chile.
2.) Call for boy cancer vaccine. A new charity is urging the U.K. government to deal with the 'ticking time bomb' that is throat cancer.
3.) BCG vaccine lab ready to start operations. The BCG Vaccine Laboratory, shut down nearly four years ago, is once again ready to serve its raison d'etre -- launch into the production mode for the BCG vaccine, which provides early life protection against tuberculosis.
4.) Volunteers wanted for bird flu vaccine. Researchers in Newcastle are doing their bit to help protect the world against a potentially deadly outbreak of the bird flu virus.
5.) No TB cattle vaccine until 2023 –- E.U. Commission. The European Commission has told Defra that a cattle vaccine for bovine TB (bTB) is unlikely to be commercially available until 2023.
Photo Credit: blakespot
Related:
- Q&A: Robert Bednarczyk, epidemiologist, on the HPV vaccine
- Can a flu shot protect against hundreds of strains?
- How big data can help you avoid the flu
- A flu vaccine that protects you for life?
- How tobacco could save our lives
This post was originally published on Smartplanet.com